Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001586962-17-000002
Filing Date
2017-11-01
Accepted
2017-11-01 16:36:19
Documents
1
Effectiveness Date
2017-11-01
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8830
  Complete submission text file 0001586962-17-000002.txt   9869
Mailing Address 2275 RESEARCH BLVD., SUITE 500 ROCKVILLE MD 20850
Business Address 2275 RESEARCH BLVD., SUITE 500 ROCKVILLE MD 20850 424-333-8537
Full Genomes Corp (Filer) CIK: 0001586962 (see all company filings)

EIN.: 900878719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-297917 | Film No.: 171169434